| Company Name: | Community Health Systems Inc | | Ticker Symbol: | CYH | | | WWW Address: | www.chs.net |
| CEO: | Wayne T. Smith | | No. of Employees: | 72,000 |
| Common Issue Type: | CS | | Business Description: | Community Health Systems Inc. provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States.
|
| | | Industry Information: | HEALTH SERVICES - Hospitals [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 43.58 | 0.88 | - | - | 42.42 | 43.59 | 41.71 | 1292312 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4,107.8 | 94.3 | 1.63 | 2.95 | 0.25 | 14.7 | 0.0 | 48.59 - 20.72 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 43.58 | $ | | PE Ratio - LTM | 14.7 | |
| Market Capitalisation | 4,107.8 | mil |
| Latest Shares Outstanding | 94.3 | mil |
| Earnings pS (EPS) | 2.95 | $ |
| Dividend pS (DPS) | 0.25 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 8 | % |
| Revenue per Employee | 180,958 | $ |
| Effective Tax Rate | 31.3 | % |
| Float | 90.9 | mil |
| Float as % of Shares Outstanding | 96.7 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 63.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 84.9 | % |
| EBITDA Margin | 21.2 | % |
| Pre-Tax Profit Margin | 3.9 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 2.1 | % |
| Return on Equity (ROE) | 11.9 | % |
| Return on Capital Invested (ROCI) | 2.8 | % |
| Current Ratio | 1.7 | |
| Leverage Ratio (Assets/Equity) | 5.8 | |
| Interest Cover | 1.8 | |
| Total Debt/Equity (Gearing Ratio) | 3.31 | |
| LT Debt/Total Capital | 77.0 | % |
| Working Capital pS | 14.96 | $ |
| Cash pS | 3.02 | $ |
| Book-Value pS | 30.53 | $ |
| Tangible Book-Value pS | -34.01 | $ |
| Cash Flow pS | 11.52 | $ |
| Free Cash Flow pS | 3.46 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.43 | |
| Price/Tangible Book Ratio | -1.28 | |
| Price/Cash Flow | 3.8 | |
| Price/Free Cash Flow | 12.6 | |
| P/E as % of Industry Group | 69.0 | % |
| P/E as % of Sector Segment | 90.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 12/06/2012 |
| Dividend Ex-Date | 12/12/2012 |
| Dividend Record Date | 12/16/2012 |
| Dividend Pay Date | 12/27/2012 |
| Dividend Amount | 250 |
| Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 8.0 |
| 5-Y Average Payout Ratio | 2.0 |
|  | | Share price performance previous 3 years |
| 
|  | | Share price performance intraday |
| 
| |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -2.4 | 99 | 9,455 | 49,564 |
| 4 Weeks | 47.31 | 41.71 | 43.53 | 0.1 | 96 | 11,074 | 210,399 |
| 13 Weeks | 48.59 | 39.35 | 41.76 | 4.4 | 96 | 12,426 | 782,815 |
| 26 Weeks | 48.59 | 28.43 | 30.01 | 45.2 | 124 | 11,712 | 1,452,278 |
| 52 Weeks | 48.59 | 20.72 | 22.66 | 92.3 | 154 | 12,928 | 3,206,090 |
| YTD | 48.59 | 30.85 | - | 41.8 | 123 | 12,494 | 1,236,896 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 43.70 | 44.76 | 44.55 | 38.08 | 34.92 | 1.63 | 1.81 |
|
| |
| GROWTH RATES | 5-Year Growh | R² of 5-Year Growth | 3-Year Growth |
| Revenue | 7.08 | 72.2 | 1.47 |
| Income | 26.57 | 40.8 | 0.19 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -22.38 | NA | 13.05 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 18.36 | NA | 2.31 |
| | | CHANGES | YTD vs. Last YTD | Curr Qtr vs. Qtr 1-Yr ago | Annual vs. Last Annual |
| Revenue % | 0.4 | 0.4 | -4.4 |
| Earnings % | -3.0 | -3.0 | 24.6 |
| EPS % | 2.4 | 2.4 | 32.3 |
| EPS $ | 0.02 | 0.02 | 0.72 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 7.68 |
| Current Ratio | 1.6 |
| Quick Ratio (Acid Test) | 1.1 |
| Liquidity Ratio (Cash) | 0.18 |
| Receivables Turnover | 6.7 |
| Average Collection Period | 54 |
| Working Capital/Equity | 46.7 |
| Working Capital pS | 13.88 |
| Cash-Flow pS | 11.65 |
| Free Cash-Flow pS | 1.07 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.33 |
| Financial Leverage Ratio (Assets/Equity) | 6.1 |
| Debt Ratio | 83.6 |
| Total Debt/Equity (Gearing Ratio) | 3.49 |
| LT Debt/Equity | 3.46 |
| LT Debt/Capital Invested | 96.3 |
| LT Debt/Total Liabilities | 68.1 |
| Interest Cover | 1.8 |
| Interest/Capital Invested | 4.31 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 15.12 |
| Tobin's Q Ratio | 0.25 |
| Current P/E Ratio - LTM | 14.70 |
| Enterprise Value (EV)/EBITDA | 9.73 |
| Enterprise Value (EV)/Free Cash Flow | 170.67 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -1.28 |
| Price/Book Ratio - LTM | 1.43 |
| Price/Cash Flow Ratio | 3.8 |
| Price/Free Cash Flow Ratio - LTM | 12.6 |
| Price/Sales Ratio | 0.31 |
| P/E Ratio (1 month ago) - LTM | 14.3 |
| P/E Ratio (26 weeks ago) - LTM | 15.0 |
| P/E Ratio (52 weeks ago) - LTM | 10.1 |
| 5-Y High P/E Ratio | 19.1 |
| 5-Y Low P/E Ratio | 4.5 |
| 5-Y Average P/E Ratio | 10.1 |
| Current P/E Ratio as % of 5-Y Average P/E | 146 |
| P/E as % of Industry Group | 69.0 |
| P/E as % of Sector Segment | 90.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 13.0 |
| PER SHARE FIGURES |
| LT Debt pS | 102.79 |
| Current Liabilities pS | 23.31 |
| Tangible Book Value pS - LTM | -34.01 |
| Book Value pS - LTM | 30.53 |
| Capital Invested pS | 129.25 |
| Cash pS - LTM | 3.02 |
| Cash Flow pS - LTM | 11.52 |
| Free Cash Flow pS - LTM | 3.46 |
| Earnings pS (EPS) | 2.95 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.75 |
| Free Cash Flow Margin 5YEAR AVG | 1.47 |
| Net Profit Margin | 2.7 |
| Net Profit Margin - 5YEAR AVRG. | 2.4 |
| Equity Productivity | 4.77 |
| Return on Equity (ROE) | 12.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.7 |
| Capital Invested Productivity | 1.07 |
| Return on Capital Invested (ROCI) | 2.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 2.7 |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | 2.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 2.0 |
| Gross Profit Margin | 84.9 |
| Gross Profit Margin - 5YEAR AVRG. | 71.3 |
| EBITDA Margin - LTM | 21.2 |
| EBIT Margin - LTM | 8.7 |
| Pre-Tax Profit Margin | 3.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 3.7 |
| Effective Tax Rate | 31.3 |
| Effective Tax Rate - 5YEAR AVRG. | 31.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 122 |
| Revenue per Employee | 180,958 |
| Net Income per Employee | 4,803 |
| Average Collection Period | 57 |
| Receivables Turnover | 6.7 |
| Day's Inventory Turnover Ratio | 65 |
| Inventory Turnover | 5.5 |
| Inventory/Sales | 2.8 |
| Accounts Payble/Sales | 6.34 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 10.21 |
| Fixed Assets Turnover | 0.99 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 33.60 |
| Revenue per $ Plant | 1.82 |
| Revenue per $ Common Equity | 4.77 |
| Revenue per $ Capital Invested | 1.07 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 71.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 57.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  





|
| |
 |  |